Диссертация (1154688), страница 24
Текст из файла (страница 24)
Reiss, E. Landmann, M.Heckmann, B. Misselwitz, L. Gortner // Arch. Gynecol. Obstet. – 2003. – Vol. 269. – P.40-44.199. Robbins, M. Early extubation attempts reduce length of stay in extremely preterminfants even if re-intubation is necessary / M. Robbins, J. Trittmann, E. Martin, K.M.Reber, et al. // J. Neonatal-Perinat.
Med. – 2015. – Vol. 8. – P. 91-97.200. Roberts, D. Antenatal corticosteroids for accelerating fetal lung maturation forwomen at risk of preterm birth [Электронный ресурс] / D. Roberts, S. Dalziel //Cochrane Database Syst. Rev. – 2006. - Vol.19 – Режим доступа:https://www.ncbi.nlm.nih.gov/pubmed/16856047.201. Rojas, M.A.
Changing trends in the epidemiology and pathogenesis of neonatalchronic lung disease / M.A. Rojas, A. Gonzalez, E. Bancalari, N. Claure, et al. // J.Pediatr. – 1995. – Vol. 126. – P. 605-610.202. Saloga, J. Increased airways responsiveness in mice depends on local challengewith antigen / J. Saloga, H. Renz, G.L. Larsen, E.W. Gelfand // Am J Respir Crit CareMed. – 1994.
– Vol. 149(1). – P. 65-70.203. Saugstad, O.D. Optimal oxygenation of extremely low birth weight infants: Ameta-analysis and systematic review of the oxygen saturation target studies / O.D.Saugstad, D. Aune // Neonatology. – 2014. – Vol. 105. – P. 55-63.204. Schaubel, D. Neonatal characteristics as risk factors for preschool asthma / D.Schaubel, H. Johansen, M. Dutta, M. Desmeules, et al. // J Asthma. – 1996. – Vol. 33. –P.
255–264.205. Schmidt, B. Caffeine therapy for apnea of prematurity / B. Schmidt, R.S. Roberts,P. Davis, L.W. Doyle, et al. // New Engl. J. Med. – 2006. – Vol. 354. – P. 2112-2121.206. Schmidt, B. Effects of targeting higher vs lower arterial oxygen saturations ondeath or disability in extremely preterm infants: A randomized clinical trial / B.171Schmidt, R.K.
Whyte, E.V. Asztalos, D. Moddemann, et al. // JAMA. – 2013. – Vol.309. – P. 2111-2120.207. Schmolzer, G.M. Non-invasive versus invasive respiratory support in preterminfants at birth: Systematic review and meta-analysis / G.M. Schmolzer, M. Kumar, G.Pichler, K. Aziz, et al. // BMJ. – 2013. – Vol. 347. - P. f5980.208.
Seger, N. Animal derived surfactant extract for treatment of respiratory distresssyndrome [Электронный ресурс] / N. Seger, R. Soll // Cochrane Database Syst. Rev. 2009. – Режим доступа: http://cochranelibrarywiley.com/doi/10.1002/14651858.CD007836/abstract.209. Shahzad, T. Pathogenesis of bronchopulmonary dysplasia: when inflammationmeets organ development / T. Shahzad, S. Radajewski, C-M. Chao, S.
Bellusci, H.Ehrhardt // Molecular and Cellular Pediatrics. – 2016. – Vol. 3. – P.23.210. Shenai, J.P. Vitamin A status of neonates with bronchopulmonary dysplasia / J.P.Shenai, F. Chytil, M.T. Stahlman // Pediatr. Res. – 1985. – Vol. 19. - P. 185-188.211. Sigurs, N. Severe respiratory syncytial virus bronchiolitis in infancy and asthmaand allergy at age 13 / N. Sigurs, P.M. Gustafsson, R. Bjarnason, F.
Lundberg, S.Schmidt, F. Sigurbergsson, B.Kjellman // Am J Crit Care Respir Med. - 2005. - Vol.171. - P.137-141.212. Siltanen, M. Preterm birth reduces the incidence of atopy in adulthood / M.Siltanen, K. Wehkalampi, P. Hovi, J.G. Eriksson, et al. // J Allergy Clin Immunol. –2011. – Vol.
127. – P. 935-42213. Siroux, V. Identifying adult asthma phenotypes using a clustering approach / V.Siroux, X. Basagaña, A. Boudier, I. Pin, et al. // Eur Respir J. – 2011. – Vol. 38(2). – P.310-317.214. Sokol, G.M. Inhaled nitric oxide therapy for pulmonary disorders of the term andpreterm infant / G.M. Sokol, G.G. Konduri, K.P. Van Meurs // Semin.
Perinatol. – 2016.– Vol. 40. – P. 356-369.215. Soto-Martínez, M.E. The current prevalence of asthma, allergic rhinitis, andeczema related symptoms in school-aged children in Costa Rica / M.E. Soto-Martínez,A. Yock-Corrales, K. Camacho-Badilla, S. Abdallah, et al. // J Asthma. – 2018. - Vol.25.
– P. 1-9.172216. Sozo, F. Altered lung function at mid-adulthood in mice following neonatalexposure to hyperoxia / F. Sozo, J.C.Horvat, A.T. Essilfie, M. O'Reilly, et al. // Respir.Physiol. Neurobiol. – 2015. – Vol. 218. – P. 21-27.217. Spergel, J.M. Atopic march: link to upper airways / J.M. Spergel // Curr OpinAllergy Clin Immunol. – 2005. – Vol. 5(1). – P. 17-21.218. Spiegler, J. Does breastmilk influence the development of bronchopulmonarydysplasia? / J.
Spiegler, M. Preuss, C. Gebauer, M. Bendiks, et al. // Pediatr. – 2016. –Vol. 169. – P. 76-80.219. Srinivasa, K. Clinical study of bronchial asthma in children aged 5 to 12 yearswith special reference to peak expiratory flow rate / K. Srinivasa, C.B. Ushakiran, S.Rudrappa // International Journal of Preventive and Therapeutic Medicine. – 2015. –Vol. 2(4). – P. 297-302.220. Sriram, S. Early blood gas predictors of bronchopulmonary dysplasia inextremely low gestational age newborns / S. Sriram, J. Condie, M.D.
Schreiber, D.G.Batton, et al. // International Journal of Pediatrics. - 2014, -Vol. 2014.– P. 1–8.221. Stein, H. Non-invasive ventilation with neurally adjusted ventilatory assist innewborns / H. Stein, J. Beck, M. Dunn // Semin. Fetal Neonatal. Med. – 2016. – Vol.21. – P. 154-161.222. Stenson, B.J. Oxygen saturation targets for extremely preterm infants after theneoprom trials / B.J. Stenson // Neonatology. – 2016.
– Vol. 109.– P. 352-358.223. Stewart, D.L. Association of RSV-related hospitalization and non-compliancewith Palivizumab among commercially insured infants: a retrospective claims analysis /D.L. Stewart, K.J. Ryan, J.G. Seare, B. Pinsky, et al. // BMC Infectious Diseases. –2013. – Vol. 13. – P. 334-345.224. Stoll, B.J. Neonatal outcomes of extremely preterm infants from the NICHDneonatal research network / B.J. Stoll, N.I.
Hansen, E.F. Bell, S. Shankaran, et al. //Pediatrics. – 2010. – Vol. 126. – P. 443-456.225. Stoll, B.J. Trends in care practices, morbidity, and mortality of extremely pretermneonates, 1993-2012 / B.J. Stoll, N.I. Hansen, E.F. Bell, M.C. Walsh, et al. // JAMA. –2015. – Vol. 314. – P. 1039-1051.173226. Subramaniam, P. Prophylactic nasal continuous positive airway pressure forpreventing morbidity and mortality in very preterm infants [Электронный ресурс] / P.Subramaniam, J.J.
Ho, P.G. Davis // Cochrane Database Syst. Rev. - 2016. - Режимдоступа: http://cochranelibrarywiley.com/doi/10.1002/14651858.CD001243.pub3/epdf.227. Sun, H. High-frequency oscillatory ventilation versus synchronized intermittentmandatory ventilation plus pressure support in preterm infants with severe respiratorydistress syndrome / H. Sun, R. Cheng, W.
Kang, H. Xiong, et al. // Care. – 2014. – Vol.59. – P. 159-169.228. Szefler, S. Budesonide Inhalation Suspension Versus Montelukast in ChildrenAged 2 to 4 Years with Mild Persistent Asthma / S. Szefler, L.G. Carlsson, T. Uryniak,J.W. Baker // J Allergy Clin Immunol: In Practice. – 2013.
– Vol. 1. – P. 58–64.229. Taha, D. Early caffeine therapy for prevention of bronchopulmonary dysplasia inpreterm infants / D. Taha, S. Kirkby, U. Nawab, K.C. Dysart, et al. // J. Matern. FetalNeonatal Med. – 2014. – Vol. 27. – P. 1698-1702.230. Tepper, R.S. Expiratory flow limitation in infants with bronchopulmonarydysplasia / R.S. Tepper, W.J. Morgan, K.Cota, L.M. Taussig // J. Pediatr.
– 1986. – Vol.109. – P. 1040-1046.231. Thome, U.H. Permissive hypercapnia in extremely low birthweight infants(phelbi): A randomised controlled multicentre trial / U.H. Thome, O. GenzelBoroviczeny, B. Bohnhorst, M. Schmid, et al. // Lancet Respir. Med. – 2015. – Vol. 3. –P. 534-543.232. Trønnes, H. Associations of maternal atopic diseases with adverse pregnancyoutcomes: a national cohort study. / H. Trønnes, A.J.
Wilcox, T. Markestad, M.C.Tollånes, R.T. Lie, D. Moster // Paediatric and perinatal epidemiology. – 2014. Vol.28(6). – P. 489-497.233. Tseng, W-N. Antenatal Dexamethasone Exposure in Preterm Infants IsAssociated with Allergic Diseases and the Mental Development Index in Children / WN. Tseng, C-C. Chen, H-R. Yu, L-T. Huang, H-C. Kuo // International Journal ofEnvironmental Research and Public Health. -2016.
– Vol. 13(12). – P. 1206.234. Tullus, K. Elevated cytokine levels in tracheobronchial aspirate fluids fromventilator treated neonates with bronchopulmonary dysplasia / K. Tullus, G.W. Noack,L.G. Burman, R.Nilsson, et al. // Eur. J. Pediatr. – 1996. – Vol. 155. – P. 112-116.174235. Uberos, J. Effectiveness of vitamin A in the prevention of complications ofprematurity / J. Uberos, M. Miras-Baldo, A. Jerez-Calero,E. Narbona-Lopez // Pediatr.
Neonatol. – 2014. – Vol. 55. – P. 358-362.236. Ünal, S. Wheezing, asthma, and atopy in premature infants at 2 years of age / S.Ünal, A. Kaya, L. Bilgin, E. Misirlioğlu, et al. // Med Sci. – 2017. – Vol. 47(2). – P.607-613.237. Vento, M. Preterm resuscitation with low oxygen causes less oxidative stress,inflammation, and chronic lung disease / M. Vento, M. Moro,R. Escrig, L.
Arruza, et al. // Pediatrics. – 2009. – Vol. 124. – P. e439-e449.238. Vom Hove, M. Pulmonary outcome in former preterm, very low birth weightchildren with bronchopulmonary dysplasia: A case-control follow-up at school age / M.Vom Hove, F. Prenzel, H.H. Uhlig, E.J. Robel-Tillig // Pediatr. – 2014. – Vol. 164. – P.40-45.239. Vrijlandt, E.J.
Gender differences in respiratory symptoms in 19-year-old adultsborn preterm / E.J. Vrijlandt, J. Gerristen, H.M. Boezen, et al. // Respir. Res. – 2005.Vol. 6.– P. 117.240. Vrijlandt, E.J. Moderate preterm children have more respiratory problems duringtheir first five years of life than children born full term / E.J. Vrijlandt, J.M. Kerstjens,E.J. Duiverman, A.F. Bos, S.A. Reijneveld // Am J Respir Crit Care Med. - 2013. – Vol.187. – P. 1234–1240.241.
Vrijlandt, L.E. Pulmonary function testing in premature infants and infants withbronchopulmonary dysplasia / L.E. Vrijlandt, E.J. Duiverman // Eur. Respir. Mon. 2010. – Vol. 47. - P. 251-262.242. Wang, H. A genome-wide association study (gwas) for bronchopulmonarydysplasia / H. Wang, K.R. St Julien, D.K. Stevenson, T.J. Hoffmann, et al. // Pediatrics.– 2013. – Vol. 132. – P. 290-297.243. Wemhoner, A.
Nutrition of preterm infants in relation to bronchopulmonarydysplasia / A. Wemhoner, D. Ortner, E. Tschirch, A. Strasak, M. Rudiger // BMC Pulm.Med. – 2011. – Vol. 11. – P. 7.244. Whitehead, A. Meta-analysis of controlled clinical trials / Whitehead, A. —Chichester, England: John Wiley & Sons Inc, 2002. — 352 p.175245. Wickens, K. A case-control study of risk factors for asthma in New Zealandchildren / K. Wickens, J.
Crane, T. Kemp, S. Lewis, et al., // Australian and NewZealand journal of public health. – 2001. – Vol. 1(25). – P. 44-49.246. Williams, H.C. The U.K. Working Party's Diagnostic Criteria for AtopicDermatitis. III. Independent hospital validation / H.C. Williams, P.G. Burney, A.C.Pembroke, R.J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
